Medical Polymers Market Report by Product Type (Medical Resins and Fibers, Medical Elastomers, Biodegradable Plastics), Application (Medical Equipment and Devices, Medical Packaging, and Others), and Region 2024-2032
세계의 의료용 폴리머 시장 규모는 2023년 219억 달러에 달했습니다. 향후 IMARC Group은 시장이 2032년까지 391억 달러에 이를 전망이고, 예측 기간 동안 6.5%의 복합 연간 성장률(CAGR)을 나타낼 것으로 예측했습니다.
의료용 폴리머는 재생 의학 및 조직 공학에서 약물 제조에 사용되는 벌크 재료, 코팅 및 의약품 나노 캐리어로 구성됩니다. 의료용 폴리머는 범용성, 강도, 유연성, 생분해성, 생체적합성, 멸균 안정성, 내피로성, 내열성, 내전성을 갖추고 있습니다. 현재 여러 제조업체가 분자량, 가교도, 결정화도, 공중합체나 블렌드, 생물활성 표면 관능기의 추가 등을 조정한 다양한 유형의 의료용 폴리머를 개발하고 있습니다. 게다가 새롭고 혁신적인 의료기기에 대한 수요가 증가함에 따라 장비 개발과 지속가능성을 지원하는 의료용 폴리머의 필요성이 세계의적으로 증가하고 있습니다.
의료용 폴리머 시장 동향
코로나 바이러스 감염(COVID-19)의 진단과 치료를 위해 면봉, 의료기기, 일회용 마스크 및 개인보호구(PPE)(PPE)의 필요성이 증가하고 있다는 것은 의료용 폴리머 수요를 끌어 올리는 중요성 한 요인 중 하나입니다. 이 외에도 감염, 만성질환, 심혈관질환 및 기타 만성질환의 유병률 증가는 진보된 의료기기의 채용을 뒷받침하고 있으며, 이는 시장 성장에 기여하고 있습니다. 또한 각국 정부는 의료 인프라를 개선하기 위해 의료 연구 개발(R&D) 프로젝트에 자금을 제공합니다. 이 밖에 고령자 인구 증가나 사고 건수 증가에 의한 장기 이식의 요구의 고조가 시장을 견인하고 있습니다. 또한, 의료 관광의 새로운 동향과 재택치료 서비스의 인기가 증가함에 따라 시장 성장이 촉진되고 있습니다. 또한 시장의 대기업은 새롭고 정교한 바이오폴리머의 도입에 주력하고 있으며, 정형외과용 안정화 재료나 혈관 스텐트에 의료용 폴리머의 응용이 강화될 것으로 예측됩니다.
이 보고서에서 다루는 주요 질문
- 세계의 의료용 폴리머 시장은 지금까지 어떻게 추이해 왔는가?
- COVID-19는 세계의 의료용 고분자 시장에 어떤 영향을 미치는가?
- 주요 지역 시장은?
- 제품 유형별 시장 분석은?
- 용도별 시장 분석은?
- 업계의 밸류체인의 다양한 단계란?
- 업계의 주요 촉진요인과 도전은 무엇인가?
- 세계의 의료용 폴리머 시장의 구조와 주요 진출기업은?
- 업계 경쟁도는?
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사의 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 주요 요약
제4장 소개
제5장 세계의 의료용 폴리머 시장
- 시장 개요
- 시장 실적
- COVID-19의 영향
- 시장 예측
제6장 시장 내역: 제품 유형별
- 의료용 수지와 섬유
- 시장 동향
- 주요 부문
- 폴리염화비닐
- 폴리프로필렌
- 폴리에틸렌
- 폴리스티렌
- 기타
- 시장 예측
- 의료용 엘라스토머
- 생분해성 플라스틱
제7장 시장 분석 : 용도별
제8장 시장 분석 : 지역별
- 북미
- 아시아태평양
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 러시아
- 기타
- 라틴아메리카
- 중동 및 아프리카
제9장 SWOT 분석
제10장 밸류체인 분석
제11장 Porter's Five Forces 분석
- 개요
- 구매자의 협상력
- 공급기업의 협상력
- 경쟁도
- 신규 진입업자의 위협
- 대체품의 위협
제12장 가격 분석
제13장 경쟁 구도
- 시장 구조
- 주요 기업
- 주요 기업 프로파일
- BASF SE
- Celanese Corporation
- Covestro AG
- DuPont
- Eastman Chemical Company
- Evonik Industries AG
- Exxon Mobil Corporation
- Huizhou Foryou Medical Device Co. Ltd.
- Kraton Corporation
- Solvay SA
BJH
The global medical polymers market size reached US$ 21.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 39.1 Billion by 2032, exhibiting a growth rate (CAGR) of 6.5% during 2024-2032.
Medical polymers comprise bulk materials, coatings, and pharmaceutical nano-carriers used for making drugs in regenerative medicine and tissue engineering. They offer versatility, strength, flexibility, biodegradability, biocompatibility, sterilization stability, and fatigue, heat, and electrical resistance. Several manufacturers are currently proving different types of medical polymers with adjusted molecular weight, crosslinking and crystallization degrees, copolymers and blends, and additional bioactive surface functionalization. Moreover, the growing demand for new and innovative medical devices is escalating the need for medical polymers worldwide to support device development and sustainability.
Medical Polymers Market Trends:
The rising need for swabs, medical devices, disposable masks, and personal protective equipment (PPE) to diagnose and treat individuals with coronavirus disease (COVID-19) represents one of the key factors impelling the demand for medical polymers. Apart from this, the increasing prevalence of infectious, chronic, cardiovascular, and other chronic diseases is propelling the adoption of advanced medical devices, which, in turn, is contributing to the market growth. Additionally, governments of numerous countries are financing medical research and development (R&D) projects to improve healthcare infrastructure. Besides this, the increasing need for organ transplantation due to the growing geriatric population and escalating number of accidents is driving the market. Furthermore, the emerging trend of medical tourism and the increasing popularity of home healthcare services are promoting the market growth. The leading market players are also focusing on introducing new and sophisticated biopolymers, which is projected to enhance the application of medical polymers in orthopedic stabilizing materials and vascular stents.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical polymers market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type and application.
Breakup by Product Type:
Medical Resins and Fibers
Polyvinyl Chloride
Polypropylene
Polyethylene
Polystyrene
Others
Medical Elastomers
Styrene Block Copolymer
Rubber Latex
Others
Biodegradable Plastics
Breakup by Application:
Medical Equipment and Devices
Medical Packaging
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being BASF SE, Celanese Corporation, Covestro AG, DuPont, Eastman Chemical Company, Evonik Industries AG, Exxon Mobil Corporation, Huizhou Foryou Medical Device Co. Ltd., Kraton Corporation and Solvay S.A.
Key Questions Answered in This Report:
- How has the global medical polymers market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global medical polymers market?
- What are the key regional markets?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global medical polymers market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Medical Polymers Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product Type
- 6.1 Medical Resins and Fibers
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Polyvinyl Chloride
- 6.1.2.2 Polypropylene
- 6.1.2.3 Polyethylene
- 6.1.2.4 Polystyrene
- 6.1.2.5 Others
- 6.1.3 Market Forecast
- 6.2 Medical Elastomers
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Styrene Block Copolymer
- 6.2.2.2 Rubber Latex
- 6.2.2.3 Others
- 6.2.3 Market Forecast
- 6.3 Biodegradable Plastics
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Application
- 7.1 Medical Equipment and Devices
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Medical Packaging
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Others
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by Region
- 8.1 North America
- 8.1.1 United States
- 8.1.1.1 Market Trends
- 8.1.1.2 Market Forecast
- 8.1.2 Canada
- 8.1.2.1 Market Trends
- 8.1.2.2 Market Forecast
- 8.2 Asia-Pacific
- 8.2.1 China
- 8.2.1.1 Market Trends
- 8.2.1.2 Market Forecast
- 8.2.2 Japan
- 8.2.2.1 Market Trends
- 8.2.2.2 Market Forecast
- 8.2.3 India
- 8.2.3.1 Market Trends
- 8.2.3.2 Market Forecast
- 8.2.4 South Korea
- 8.2.4.1 Market Trends
- 8.2.4.2 Market Forecast
- 8.2.5 Australia
- 8.2.5.1 Market Trends
- 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
- 8.2.6.1 Market Trends
- 8.2.6.2 Market Forecast
- 8.2.7 Others
- 8.2.7.1 Market Trends
- 8.2.7.2 Market Forecast
- 8.3 Europe
- 8.3.1 Germany
- 8.3.1.1 Market Trends
- 8.3.1.2 Market Forecast
- 8.3.2 France
- 8.3.2.1 Market Trends
- 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
- 8.3.3.1 Market Trends
- 8.3.3.2 Market Forecast
- 8.3.4 Italy
- 8.3.4.1 Market Trends
- 8.3.4.2 Market Forecast
- 8.3.5 Spain
- 8.3.5.1 Market Trends
- 8.3.5.2 Market Forecast
- 8.3.6 Russia
- 8.3.6.1 Market Trends
- 8.3.6.2 Market Forecast
- 8.3.7 Others
- 8.3.7.1 Market Trends
- 8.3.7.2 Market Forecast
- 8.4 Latin America
- 8.4.1 Brazil
- 8.4.1.1 Market Trends
- 8.4.1.2 Market Forecast
- 8.4.2 Mexico
- 8.4.2.1 Market Trends
- 8.4.2.2 Market Forecast
- 8.4.3 Others
- 8.4.3.1 Market Trends
- 8.4.3.2 Market Forecast
- 8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast
9 SWOT Analysis
- 9.1 Overview
- 9.2 Strengths
- 9.3 Weaknesses
- 9.4 Opportunities
- 9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
- 11.1 Overview
- 11.2 Bargaining Power of Buyers
- 11.3 Bargaining Power of Suppliers
- 11.4 Degree of Competition
- 11.5 Threat of New Entrants
- 11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
- 13.1 Market Structure
- 13.2 Key Players
- 13.3 Profiles of Key Players
- 13.3.1 BASF SE
- 13.3.1.1 Company Overview
- 13.3.1.2 Product Portfolio
- 13.3.1.3 Financials
- 13.3.1.4 SWOT Analysis
- 13.3.2 Celanese Corporation
- 13.3.2.1 Company Overview
- 13.3.2.2 Product Portfolio
- 13.3.2.3 Financials
- 13.3.2.4 SWOT Analysis
- 13.3.3 Covestro AG
- 13.3.3.1 Company Overview
- 13.3.3.2 Product Portfolio
- 13.3.3.3 Financials
- 13.3.4 DuPont
- 13.3.4.1 Company Overview
- 13.3.4.2 Product Portfolio
- 13.3.4.3 Financials
- 13.3.4.4 SWOT Analysis
- 13.3.5 Eastman Chemical Company
- 13.3.5.1 Company Overview
- 13.3.5.2 Product Portfolio
- 13.3.5.3 Financials
- 13.3.5.4 SWOT Analysis
- 13.3.6 Evonik Industries AG
- 13.3.6.1 Company Overview
- 13.3.6.2 Product Portfolio
- 13.3.6.3 Financials
- 13.3.6.4 SWOT Analysis
- 13.3.7 Exxon Mobil Corporation
- 13.3.7.1 Company Overview
- 13.3.7.2 Product Portfolio
- 13.3.7.3 Financials
- 13.3.7.4 SWOT Analysis
- 13.3.8 Huizhou Foryou Medical Device Co. Ltd.
- 13.3.8.1 Company Overview
- 13.3.8.2 Product Portfolio
- 13.3.9 Kraton Corporation
- 13.3.9.1 Company Overview
- 13.3.9.2 Product Portfolio
- 13.3.9.3 Financials
- 13.3.10 Solvay S.A.
- 13.3.10.1 Company Overview
- 13.3.10.2 Product Portfolio
- 13.3.10.3 Financials
- 13.3.10.4 SWOT Analysis
